The Claim
In patients with type 2 diabetes and HbA1c levels below 7%, a red blood cell lifespan shorter than 90 days is associated with a higher estimated HbA1c derived from continuous glucose monitoring or average blood glucose measurements, suggesting that actual long-term glycemic exposure is greater than what is indicated by measured HbA1c, leading to an underestimation of glycemic control.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
If someone with type 2 diabetes has good HbA1c numbers but their red blood cells don’t live as long, their blood sugar might actually be higher than the test shows — meaning the test could be giving them a too-rosy picture of their sugar control.
See the scientific wording
In type 2 diabetes patients with HbA1c <7%, a shorter red blood cell lifespan (<90 days) is associated with higher estimated HbA1c (eHbA1c) derived from average blood glucose, indicating that actual glycemic exposure is greater than what HbA1c reflects, leading to underestimation of long-term blood glucose control.
What the research says
1 studyThe study shows that when red blood cells don’t live as long, the HbA1c test can make blood sugar look better than it really is, which means doctors might think diabetes is under control when it’s not.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.